Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis
The nature and extent of persistent neuropsychiatric symptoms after COVID-19 are not established. To help inform mental health service planning in the pandemic recovery phase, we systematically determined the prevalence of neuropsychiatric symptoms in survivors of COVID-19. <br> For this pre-r...
主要な著者: | Badenoch, J, Rengesamy, E, Watson, C, Jansen, K, Chakraborty, S, Sundaram, R, Hafeez, D, Burchill, E, Saini, A, Thomas, L, Cross, B, Hunt, C, Conti, I, Ralovska, S, Hussain, Z, Butler, M, Pollak, T, Koychev, I, Michael, B, Holling, H, Rogers, J, Rooney, A |
---|---|
その他の著者: | SARS-CoV-Neuro Collaboration |
フォーマット: | Journal article |
言語: | English |
出版事項: |
Oxford University Press
2021
|
類似資料
-
Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives
著者:: Rogers, JP, 等
出版事項: (2021) -
Brexpiprazole versus placebo or other antidepressive agents for treating depression
著者:: Ralovska, S, 等
出版事項: (2021) -
Blood-based ATN biomarkers of Alzheimer’s disease: a meta-analysis
著者:: Koychev, I, 等
出版事項: (2021) -
Neuropsychiatric sequelae of head injury
著者:: S Chaudhary, 等
出版事項: (2005-06-01) -
A meta-analysis of the relationship between sleep and β-Amyloid biomarkers in Alzheimer’s disease
著者:: Jana Harenbrock, 等
出版事項: (2023-12-01)